Hypertension and Diagnosis of Parkinson’s Disease: A Meta-Analysis of Cohort Studies

Abstract

BackgroundHypertension has been associated with cognitive dysfunction in the general population and patients with Alzheimer’s disease (AD). However, there are contradictory data regarding the potential association between hypertension and diagnosis of Parkinson’s disease (PD), the second most common neurodegenerative disorder after AD. The purpose of this meta-analysis is to synthesize data from cohort studies to explore the potential association between preexisting hypertension and subsequent PD diagnosis.MethodsThe PubMed and Embase databases were searched to identify all relevant studies. Two independent investigators performed the data extraction. Eligible cohort studies providing risk and precision estimates related to hypertension and PD were selected. Pooled risk ratios (RRs) with 95% confidence interval (CI) were calculated by using a random-effects model or a fixed-effects model. Sensitivity analyses after excluding one study at a time were performed to assess the stability of the results. Publication bias was assessed with Begg’s test and Egger’s test.ResultsSeven cohort studies were identified, including 3,170 persons who were confirmed to have developed PD and 339,517 participants who did not have PD during follow-up. The onset of hypertension before PD diagnosis was significantly associated with an increased risk of motor stage PD (RR = 1.799, 95% CI [1.066–3.037]). This relationship was further confirmed by secondary analyses based on estimates adjusted for potential vascular confounders (RR = 1.319, 95% CI [1.073–1.622]). After excluding one study at a time, the sensitivity analyses still showed that hypertension history was significantly associated with an increased risk of motor stage PD (RR with 95% CI ranging from 1.11 [1.075–1.35] to 1.42 [1.65–1.83]). No publication bias was observed in this meta-analysis.ConclusionThe findings of this meta-analysis suggest that hypertension may be a risk factor for motor stage PD, which may provide novel insights into the etiology and pathogenesis of this neurodegenerative disorder. However, large-scale well-designed studies that consider various confounders are still needed to further verify and clarify the association between hypertension and PD diagnosis.

Association between Hypertension and the Risk of Parkinson’s Disease: A Meta-Analysis of Analytical Studies

“…And the results from leave-one-out sensitivity analysis also indicated that hypertension might increase the risk of PD. And these results were the same as those of the previous study, which included 6 cohort articles conducted by Hou et al [49]. Meanwhile, compared with Hou et al [49], our meta-analysis contained influence analysis.…”

“…And these results were the same as those of the previous study, which included 6 cohort articles conducted by Hou et al [49]. Meanwhile, compared with Hou et al [49], our meta-analysis contained influence analysis. In influence analysis, 4 studies had an excessive influence on the pooled RR.…”

An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study

“…Trend analysis for common underlying causes of death with a contributing cause of hypertension were also conducted. Underlying causes included atherosclerotic heart disease (I25.1), myocardial infarction (I21), stroke (I64), Alzheimer's disease (G30), COPD unspecified (J44.9) [16], Parkinson's disease (G20), non-insulin-dependent diabetes (E11), vascular dementia (F01) [17], and falls (W00-W19) [18].…”

What are the considerations for anti-hypertensive treatment in patients with Parkinson’s disease?

“…The association between arterial hypertension (AH) and PD remains controversial [12]. AH is even discussed as a risk factor for PD [12].…”